RESUMEN
The synthesis of carbon quantum dots (CQDs) using chemical precursors with different organic groups is a strategy to improve optical properties and expand applications in several fields of research such as Analytical Chemistry. Ascorbic acid and riboflavin are widely used in human food supplementation, making quality monitoring of these vitamin supplements relevant and necessary. In this work, disodium ethylenediaminetetraacetic, sodium thiosulfate and urea were applied to obtain CQDs through a single-step microwave-assisted synthesis. The CQDs were characterized by transmission electron microscopy, X-ray photoelectron spectroscopy, X-ray powder diffraction, infrared spectroscopy, zeta potential measurements, ultraviolet-visible spectroscopy and photoluminescence spectroscopy. The synthesized nanoparticles exhibited satisfactory and stable optical properties with luminescence at 430 nm, water solubility, and fluorescence quantum yield of 8.9 %. They were applied in the quantification of ascorbic acid and riboflavin in vitamin supplements. The fluorescence mechanisms observed were dynamic quenching for the CQDs/Cr(VI) sensor, followed by a return of fluorescence in the presence of ascorbic acid, and static quenching and inner filter effect in the interaction with riboflavin. Factorial designs 23 and 24 were used to optimize the analytical parameters. The CQDs/Cr(VI) sensor used in the determination of ascorbic acid, employing an on-off-on strategy, resulted in a linear range of 0.5 to 50 µg mL-1 and a limit of detection of 0.15 µg mL-1. The ratiometric fluorescence used in the determination of riboflavin resulted in a linear range of 0.1 to 7 µg mL-1 and a limit of detection of 0.09 µg mL-1. The analytical results for ascorbic acid were compared to the reference method of the Brazilian pharmacopeia, showing accuracy and precision according to the Brazilian Health Regulation Agency. Therefore, the synthesized CQDs were used to determine ascorbic acid and riboflavin in vitamin supplements, and the application of this nanomaterial can be expanded to different analytes and matrices, using simple and low-cost analysis techniques.
Asunto(s)
Ácido Ascórbico , Carbono , Suplementos Dietéticos , Microondas , Puntos Cuánticos , Riboflavina , Espectrometría de Fluorescencia , Puntos Cuánticos/química , Riboflavina/análisis , Ácido Ascórbico/análisis , Carbono/química , Espectrometría de Fluorescencia/métodos , Suplementos Dietéticos/análisis , Límite de Detección , Vitaminas/análisis , Difracción de Rayos XRESUMEN
Background: US FDA defines: dietary supplements is a product that intended to supplement a person's diet, it's generally consist of at least one or more of the following dietary ingredients, vitamin, minerals, a herb or other botanical and amino acid by increasing the daily consumptions of an extract metabolite concentration, constitute or combinations of these medication. Excessive and inappropriate use of medicines has been recognised as a public health problem resulting in increased likelihood of adverse drug event, drug interaction, and inappropriate drug prescribing and increased cost. Material and Methods: This was the cross-sectional study conducted in year 2022 at Pimpri Chinchwad (Pune). The total 250 questionaires are distributed and from that 226 response were received. Target population consist of community pharmacists working in the drug store in this area (n=226). Results: Data was represented in three domains of study i. e. awareness, knowledge and attitude. Correlation coefficient using Pearson's method were determined to evaluate strength of correlation between awareness-knowledge, Knowledge-attitude and awareness-attitude. Correlation coefficient were calculated by comparing most relevant and equal number of questions. Conclusion: The study demonstrated positive attitude among surveyed community pharmacists in Pune, India. There is lacuna in accurate and adequate awareness, knowledge and attitude of vitamin deficiency, efficiency, recommended daily allowance (RDA), toxicity and interactions among pharmacist as one of the stakeholders of healthcare in India. Few of the remedies viz. framing of guidelines, inclusion in formal education syllabus, continuous education, updation exams etc. may be of use.
RESUMEN
OBJECTIVE: Micronutrient deficiencies are common complications after bariatric surgery as alterations to the gastrointestinal tract change absorption. Patients are recommended to take supplements including multivitamins, B complex, calcium, vitamin D, and iron after bariatric surgery, and can take these as specifically formulated vitamins for post-bariatric patients or separate vitamin supplements. We investigated the compliance, efficacy, and cost of specifically formulated vitamins for post-bariatric patients in comparison to separate vitamin supplements. METHODS: We surveyed 126 post-bariatric adult patients between February 1, 2022, and August 31, 2022, who had undergone bariatric surgery between 2014 and 2021 to assess the type of supplements taken, compliance, and cost. Demographics, type of bariatric surgery, and serum micronutrient levels were evaluated for all patients. RESULTS: There were 51 patients taking formulated vitamins and 75 patients taking separate vitamins. The formulated vitamin group demonstrated greater adherence to optimal vitamin dosage (formulated vitamin group, 76.5% vs. separate supplement group, 30.7%; p < 0.001) and higher compliance (formulated vitamin group, 90.2% vs. separate supplement group, 66.7%; p = 0.002). The costs associated with both groups were comparable. No significant difference was observed in the incidence of micronutrient deficiency between the groups. CONCLUSIONS: Our study shows that formulated vitamins do not offer significant difference in micronutrient levels or cost compared to separate standard vitamin supplements. However, formulated bariatric vitamins have improved compliance compared to separate vitamin supplements.
Asunto(s)
Cirugía Bariátrica , Obesidad Mórbida , Adulto , Humanos , Vitaminas/uso terapéutico , Obesidad Mórbida/cirugía , Vitamina A , Vitamina KRESUMEN
Background: Multi-vitamin multi-mineral (MVMM) products often come in several single-substance capsules from different manufacturers. However, attempts to mix several vitamins and minerals into one MVMM product have been complicated and often involve legal concerns. This study aimed to comparatively investigate the changes in laboratory parameters and the quality of life (QOL) among individuals who received different MVMM formulations. Methods: This three-arm non-randomized controlled trial was conducted at VitalLife Scientific Wellness Center (VSWC), Bangkok, Thailand. A total of 72 healthy adult individuals with total serum 25-(OH)D level of 20-29 ng/ml were invited to choose from the three available options, namely, (1) Hydro-Cell-Key (HCK®, Hepart AG, Switzerland) contains vitamin D3 2,000 IU, vitamin C 1,000 mg, vitamin E 166 mg, vitamin A 1 mg, coenzyme Q10 30 mg, natural carotenoids 8 mg, and citrus flavonoids 200 mg in granule formulation; (2) VTL-7 (VWSC) contains similar vitamins and minerals but in capsule formulation; and (3) placebo capsule (no supplement). The 36-Item Short-Form Health Survey (SF-36) was used to measure QOL at baseline, month 3 and 6. A generalized estimating equation (GEE) was used to compare the repeated-measure outcomes across the three groups. This study was registered at the Thai Clinical Trial Registration (TCTR20190205002) and approved by the Bumrungrad International Institutional Review Board (BI-IRB No.258-10-18PhFub). Results: Both VTL-7 and HCK saw a significantly higher increase in vitamin D than placebo at months 3 and 6, i.e., VTL-7 from 25.15 ± 2.13 to 35.53 ± 6.11 (p < 0.001) and 33.38 ± 6.89 (p < 0.001); HCK from 24.25 ± 3.08 to 28.43 ± 5.93 (p = 0.005) and 27.40 ± 5.24 (p = 0.012); and placebo from 24.00 ± 2.73 to 23.05 ± 4.39 (p = 0.273) and 22.30 ± 6.23 (p = 0.200), respectively. Similarly, ß-carotenoids of VTL-7 vs. HCK groups significantly increased from 0.88 ± 0.68 vs. 0.94 ± 0.55 at baseline to 3.03 ± 1.79 (p < 0.001) vs. 1.09 ± 0.61 (p = 0.125) and 3.26 ± 1.74 (p < 0.001) vs. 1.15 ± 0.66 (p = 0.064), respectively. These findings were corroborated through the GEE analysis. Other micronutrients at months 3 and 6 did not increase significantly from baseline in any group. The overall QOL among the three groups in terms of physical (p = 0.560) and mental (p = 0.750) health increased but was not statistically significant. Conclusion: The supplements of MVMM in capsule formulation increased the serum levels of some micronutrients to a higher extent than that of granule formulation. Participant adherence remains a potential confounder and should be further explored. Clinical Trial Registration: identifier: TCTR20190205002.
RESUMEN
BACKGROUND: Neural tube defects (NTDs) encompass a variety of distinct types. We assessed if the preventive effect of folic acid (FA) varied by NTD type and infant sex. METHODS: We examined all pregnancies with NTD status confirmation from a pregnancy-monitoring system in selected locations in northern and southern regions of China between 1993 and 1996. Women who took 400 µg of FA daily during 42 days after last menstrual period were considered FA users. We analyzed NTD prevalence by FA use status, NTD type, geographic region, and infant sex. RESULTS: Among 626,042 pregnancies, 700 were affected by an NTD. Among FA nonusers, 65 pregnancies (8.8 per 10,000) in the north and 51 pregnancies (1.2 per 10,000) in the south were affected by one of the two rare NTDs, that is, craniorachischisis, iniencephaly. FA use prevented occurrence of these two rare NTDs and reduced the prevalence of spina bifida (SB) by 78% (from 17.9 to 3.9 per 10,000) in the north and 51% (from 2.4 to 1.2 per 10,000) in the south. Among FA users, SB prevalence, including SB with high lesion level, was significantly reduced in both geographic regions. FA use reduced prevalence of anencephaly and encephalocele by 85% and 50%, respectively in the north, while it did not reduce the prevalence of these two NTDs in the south. There was a greater reduction in NTD prevalence in female than in male infants and fetuses. CONCLUSIONS: This is the first study to show that FA prevents the entire spectrum of NTD types.
Asunto(s)
Anencefalia , Defectos del Tubo Neural , Disrafia Espinal , Anencefalia/epidemiología , Anencefalia/prevención & control , China/epidemiología , Suplementos Dietéticos , Femenino , Ácido Fólico , Humanos , Masculino , Defectos del Tubo Neural/epidemiología , Defectos del Tubo Neural/prevención & control , Embarazo , Disrafia Espinal/epidemiología , Disrafia Espinal/prevención & controlRESUMEN
Vitamin and mineral supplements (VMS) are widely available and commonly used. Little is known about patterns of poisoning exposures to VMS in the Australian population. We performed a retrospective study of calls to the New South Wales Poisons Information Centre (NSWPIC), July 2014-June 2019. NSWPIC is Australia's largest PIC, taking approximately 100 000 calls/year (50 % of Australian poisoning calls) from healthcare professionals and members of the public. We conducted additional analyses on Fe exposures due to their high risk of acute toxicity. There were 10 944 VMS exposures reported to NSWPIC during the study period, increasing 9·6 % per annum over a 5-year period (95 % CI, 7·2, 12·1 %). Toddlers (1-4 years) accounted for 41·5 % (4546) of cases. Agents most commonly involved were multivitamins (n 3610), vitamin D (n 2080), Fe (n 1533) and Mg (n 804). In 17·7 % (1934) of cases, the call originated from hospital or the patient was referred to hospital by NSWPIC. Fe exposures increased by 14·0 % per year (95 % CI, 9·5, 18·5 %), and most were associated with high-strength products (> 45 mg elemental Fe per unit dose, n 1036). Fe exposures were hospitalised in 38 % of cases (n 583). We conclude that VMS exposures are increasing in Australia. Although most exposures can be managed at home, many required hospitalisation. Fe exposures are increasing and had higher rates of hospitalisation than other agents. VMS are often considered safe and without the potential for adverse effects, highlighting the importance of public education into the potential risks of misuse of these products.
Asunto(s)
Venenos , Australia/epidemiología , Humanos , Centros de Información , Minerales , Centros de Control de Intoxicaciones , Estudios Retrospectivos , VitaminasRESUMEN
Tinnitus is the perception of sound in the absence of any external stimulus. Oxidative stress is possibly involved in its pathogenesis and a variety of antioxidant compounds have been studied as potential treatment approaches. The objective of the present study was to assess the effects of antioxidant supplementation in tinnitus patients. This is a randomized, double-blind, placebo-controlled clinical trial. Patients (N = 70) were randomly allocated to antioxidant supplementation (N = 35) or to placebo (N = 35) for a total of 3 months. Demographic, anthropometric, clinical, and nutritional data were collected. Serum total antioxidant capacity (TAC), oxidized LDL (oxLDL), and superoxide dismutase (SOD), tinnitus loudness, frequency, and minimum masking level (MML), and scores in Tinnitus Handicap Inventory questionnaire (THI), Tinnitus Functional Index (TFI), and Visual Analogue Scale (VAS) were evaluated at baseline and follow-up. Tinnitus loudness and MML significantly decreased from baseline to post measure (p < 0.001) only in the antioxidant group, the overall change being significantly different between the two groups post-intervention (p < 0.001). THI and VAS decreased only in the antioxidant group. Differences in changes in serum TAC, SOD, and oxLDL post-intervention were insignificant. In conclusion, antioxidant therapy seems to reduce the subjective discomfort and tinnitus intensity in tinnitus patients.
Asunto(s)
Antioxidantes/administración & dosificación , Suplementos Dietéticos , Pérdida Auditiva/terapia , Acúfeno/terapia , Adulto , Antioxidantes/análisis , Método Doble Ciego , Femenino , Pérdida Auditiva/sangre , Humanos , Lipoproteínas LDL/sangre , Masculino , Persona de Mediana Edad , Oxidación-Reducción , Superóxido Dismutasa/sangre , Acúfeno/sangre , Resultado del TratamientoRESUMEN
This study was conducted to evaluate the effects of supplementation with different levels of mineral-vitamin supplement (MVS) on performance and health of fattening lambs. Thirty-nine fattening male Ghezel× Afshar lambs (averaging body weight 31.02 ± 3.46 kg) were used in a completely randomized design for a period of 84 days. Treatments consisted of 0 (CON), 15 (MVS15), or 30 (MVS30) g/day of MVS mixed into the concentrate. The results showed that inclusion of MVS in the ration linearly enhanced body weight (BW) on day 29 (P < 0.002), 45 (P = 0.05), and 70 (P < 0.002). Dry matter intake (DMI) was increased linearly (P < 0.02) and quadratically (P < 0.001) with increasing supplement between days 58 and 70. Overall DMI tended (P = 0.1) to be greater for the MVS 30 treatment. Total average daily gain (ADG), ADG between days 16 and 29, days 58 and 70, total gain: feed ratio, gain: feed ratio between days 16-29 and days 58-70 linearly increased with increasing amount of MVS in the ration (P < 0.01). The days with loose fecal scores were not affected by treatments (P > 0.05). There was a linear and quadratic (P < 0.01) effect on serum Ca concentration. Phosphorus concentration tended to quadratically increase (P = 0.06) with MVS. Blood serum Zn increased linearly (P = 0.01) with increasing level of MVS. Collectively, the results showed that, under the conditions of the current experiment, MVS addition to ration improved performance of fattening lambs.
Asunto(s)
Minerales/administración & dosificación , Minerales/sangre , Ovinos/fisiología , Vitaminas/administración & dosificación , Alimentación Animal/análisis , Animales , Dieta/veterinaria , Suplementos Dietéticos/análisis , Relación Dosis-Respuesta a Droga , Irán , Masculino , Distribución Aleatoria , Ovinos/sangre , Ovinos/crecimiento & desarrolloRESUMEN
BACKGROUND: Use of multinutrient fortifiers is standard of care for small preterm infants fed exclusively human milk. However, adequacy of human milk fortifiers (HMFs) to meet the recommended intake for macronutrients and micronutrients is now known. MATERIALS AND METHODS: Nutrient content of human milk fortified according to manufacturer's recommendations was compared at isocaloric levels for 1 human milk-based (HMF-A), 2 bovine milk protein-based (HMF-B, HMF-C), and 2 preterm infant formulas (PTF-B, PTF-C). In addition, 4 multivitamin supplements were compared. RESULTS: At 130 kcal/kg, intake of macronutrients was similar to the recommendation, although deficient and excess intake of micronutrient occurred with all fortifiers. Four to 9 micronutrients were absent in HMF or PTF (biotin, choline, inositol, carnitine, taurine, molybdenum, iodine, selenium, or chromium). For the remainder, HMF resulted in deficient intake for 1-13 micronutrients, occurring most frequently with HMF-A. Excess micronutrients (3-15 at <50% and 1-3 at 109%-437%) occurred with all HMF and most frequently with HMF-B and HMF-C. At 150 kcal/kg, deficient intake improved but generally remained below recommendation, while excess intake became exaggerated. PTF and multivitamin formulations do not fully compensate for the deficiencies and can result in extremely high micronutrient intake. CONCLUSIONS: At the recommended energy intake for very low birth weight infants, many micronutrients are absent or are present in grossly inadequate amounts, and several micronutrients are in excess. Reformulation of HMF is urgently needed since PTF or multivitamin supplement only partially corrects some deficiencies while providing some nutrients in excess.
Asunto(s)
Peso al Nacer , Alimentos Fortificados , Fórmulas Infantiles/normas , Recién Nacido de muy Bajo Peso , Leche Humana , Nutrientes/análisis , Necesidades Nutricionales , Animales , Bovinos , Proteínas en la Dieta/administración & dosificación , Suplementos Dietéticos , Ingestión de Energía , Humanos , Lactante , Fórmulas Infantiles/química , Recién Nacido , Recien Nacido Prematuro , Micronutrientes/administración & dosificación , Micronutrientes/análisis , Micronutrientes/deficiencia , Proteínas de la Leche/administración & dosificación , Nutrientes/administración & dosificación , Estado Nutricional , Aumento de PesoRESUMEN
BACKGROUND: There are few studies of the association between the use of antioxidant vitamin supplements and the risk of Alzheimer's disease (AD). Cognitive decline is generally viewed as part of the continuum between normal aging and AD. OBJECTIVE: To evaluate whether the use of vitamin E and C supplements is associated with reduced risks of cognitive impairment, not dementia (CIND), AD, or all-cause dementia in a representative sample of older persons ≥65 years old. METHODS: Data from the Canadian Study of Health and Aging (1991-2002), a cohort study of dementia including 3 evaluation waves at 5-yearly intervals, were used. Exposure to vitamins E and C was self-reported at baseline in a risk factor questionnaire and/or in a clinical examination. RESULTS: The data set included 5269 individuals. Compared with those not taking vitamin supplements, the age-, sex-, and education-adjusted hazard ratios of CIND, AD, and all-cause dementia were, respectively, 0.77 (95% CI = 0.60-0.98), 0.60 (95% CI = 0.42-0.86), and 0.62 (95% CI = 0.46-0.83) for those taking vitamin E and/or C supplements. Results remained significant in fully adjusted models except for CIND. Similar results were observed when vitamins were analyzed separately. CONCLUSIONS: This analysis suggests that the use of vitamin E and C supplements is associated with a reduced risk of cognitive decline. Further investigations are needed to determine their value as a primary prevention strategy.
Asunto(s)
Enfermedad de Alzheimer/prevención & control , Antioxidantes/uso terapéutico , Ácido Ascórbico/uso terapéutico , Disfunción Cognitiva/prevención & control , Vitamina E/uso terapéutico , Anciano , Envejecimiento/efectos de los fármacos , Envejecimiento/psicología , Antioxidantes/administración & dosificación , Ácido Ascórbico/administración & dosificación , Canadá , Estudios de Cohortes , Demencia/tratamiento farmacológico , Suplementos Dietéticos , Femenino , Humanos , Masculino , Modelos de Riesgos Proporcionales , Factores de Riesgo , Encuestas y Cuestionarios , Vitamina E/administración & dosificaciónRESUMEN
Objetivo evaluar la costo-efectividad relativa del uso de vitamina a en los niños menores de 5 años en la disminución de eventos de diarrea, malaria y la mortalidad, bajo la perspectiva del sistema de salud colombiano (SGSSS). Materiales y Métodos se construyó unárbol de decisión con muertes evitadas como desenlace. Las probabilidades se extrajeron de la literatura y los costos de fuentes oficiales. El umbral de costo-efectividad fue tres veces el producto interno bruto (PIB) per cápita colombiano de 2012. Se realizaron análisis de sensibilidad determinísticos, probabilísticos y curva de aceptabilidad. Resultados En una cohorte de cien mil niños, la administración de vitamina a, frente no hacerlo, representaría un ahorro en costos de atención médica de $ 340.306.917, debido a que reduce el número de eventos de diarrea (4.268) y de malaria (76), así como los casos en los que se requiere hospitalización. En todos los análisis de sensibilidad se obtuvo un ahorro para el sistema. Conclusión Dentro del sistema de salud colombiano, la suplementación con vitamina a para niños menores de 5 años, comparado con no hacerlo, es la estrategia menos costosa y más efectiva (dominante).
Objective Evaluating the relative cost-effectiveness of using vitamin A in children aged less than 5-years-old regarding the reduction of events involving diarrhoea, malaria and mortality from the Colombian health-related social security system (CHSSS). Materials and Methods A decision tree was constructed, using deaths averted as outcome. Probabilities were taken from the pertinent literature and costs from official sources. The cost-effectiveness threshold was three times greater than the per capita Colombian gross domestic product (GDP) in 2012. Probabilistic and deterministic sensitivity analyses were made and cost effectiveness acceptability curves were drawn. Results Providing a cohort of 100,000 children with vitamin A (as opposed to not doing so) would represent a saving regarding medical attention costs of $ 340,306,917 due to the number of events involving diarrhea (4,268) and malaria (76), having become reduced, as well as cases requiring hospitalization. A saving for the CHSSS was consistently obtained in sensitivity analysis. Conclusion Providing vitamin supplements for children aged less than 5 years-old would seem to be the least costly and most effective (dominant) strategy for the CHSSS, i.e. compared to not doing so).
Asunto(s)
Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Análisis Costo-Beneficio , Diarrea/prevención & control , Suplementos Dietéticos , Malaria/prevención & control , Deficiencia de Vitamina A/prevención & control , Vitamina A/uso terapéutico , Vitaminas/uso terapéutico , Colombia/epidemiología , Árboles de Decisión , Diarrea/economía , Diarrea/etiología , Diarrea/mortalidad , Suplementos Dietéticos/economía , Costos de los Medicamentos/estadística & datos numéricos , Malaria/economía , Malaria/etiología , Malaria/mortalidad , Programas Nacionales de Salud/economía , Resultado del Tratamiento , Deficiencia de Vitamina A/economía , Deficiencia de Vitamina A/etiología , Vitamina A/economía , Vitaminas/economíaRESUMEN
Vitamin D deficiency has been identified in many British children. This condition has many deleterious effects on their health. Taking vitamin D status into account needs to become a daily element of primary care practice, both in antenatal and postnatal situations. It is probable that a significant improvement in reducing chronic diseases in adulthood will result from a more proactive approach in children.
RESUMEN
The role of calcium in the prevention of bone loss in later life has been well established but little data exist on the adequacy of calcium intakes in elderly Australian women. The aim of this study was to compare the dietary intake including calcium of elderly Australian women with the Australian dietary recommendation, and to investigate the prevalence of calcium supplement use in this population. Community-dwelling women aged 70-80 years were randomly recruited using the Electoral Roll for a 2-year protein intervention study in Western Australia. Dietary intake was assessed at baseline by a 3-day weighed food record and analysed for energy, calcium and other nutrients. A total of 218 women were included in the analysis. Mean energy intake was 7,140 ± 1,518 kJ/day and protein provided 19 ± 4% of energy. Mean dietary calcium intake was 852 ± 298 mg/day, which is below Australian recommendations. Less than one quarter of women reported taking calcium supplements and only 3% reported taking vitamin D supplements. Calcium supplements by average provided calcium 122 ± 427 mg/day and when this was taken into account, total calcium intake increased to 955 ± 504 mg/day, which remained 13% lower than the Estimated Average Requirement (EAR, 1,100 mg/day) for women of this age group. The women taking calcium supplements had a higher calcium intake (1501 ± 573 mg) compared with the women on diet alone (813 ± 347 mg). The results of this study indicate that the majority of elderly women were not meeting their calcium requirements from diet alone. In order to achieve the recommended dietary calcium intake, better strategies for promoting increased calcium, from both diet and calcium supplements appears to be needed.